Albert Labs Chief Medical Officer Dr. Malcom Barratt-Johnson joined Steve Darling from Proactive to share details about the private company with a focus on the emerging field of psychedelic-assisted therapy and research. Dr. Barratt-Johnson talks about the origins of Albert Labs and about their recent news the company has done a reverse takeover of ME Resource Corp.
Albert Labs looking to investigate the use of psychedelics to treat anxiety in cancer patients
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Albert Labs named herein, including the promotion by the Company of Albert Labs in any Content on the Site, the Company receives from said...FOR OUR FULL DISCLAIMER CLICK HERE